ID

38047

Descrizione

A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo. This is a trial designed to test if a treatment, losartan, may decrease the progression of Chronic Obstructive Pulmonary Disease (COPD). Losartan is an angiotensin receptor blocking agent, commonly used as an antihypertensive agent, which has been shown to alter cardiac remodeling after myocardial infarction and renovascular remodeling in diabetes-mellitus. In this trial participants with mild to severe COPD, with Computed Tomography (CT) evidence of emphysema (5-35% of voxels with < -950 Hounsfield Units), will be randomly assigned to receive 100mg/day of losartan or placebo for 48 weeks. The primary outcome measure will be the rate of progression of emphysema, quantified as the percent of lung voxels with a density less than -950 HU as measured by High Resolution CT (HRCT, from baseline to 48 weeks.

Keywords

  1. 12/09/19 12/09/19 -
Titolare del copyright

JHSPH Center for Clinical Trials

Caricato su

12 settembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Losartan Effects on Emphysema Progression NCT02696564

Eligibility Criteria

  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Does the participant have mild to severe COPD: Ratio of forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) less than or equal to 0.70, FEV1 20-80% of predicted?
Descrizione

Mild to severe COPD

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2945599
UMLS CUI [1,2]
C0024117
UMLS CUI [2,1]
C0205082
UMLS CUI [2,2]
C0024117
UMLS CUI [3]
C0438193
UMLS CUI [4]
C0860907
Is the participant a current or former smoker?
Descrizione

Current or former smoker

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3241966
UMLS CUI [2]
C0337671
Does the participant have a HRCT scan with 5-35% of voxels with density less than -950 Hounsfield Units (HU)?
Descrizione

HRCT scan

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0412612
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C2700259
UMLS CUI [1,4]
C0178587
UMLS CUI [1,5]
C0205251
Does the participant have the ability to understand and willingness to sign consent documents?
Descrizione

Informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1273101
UMLS CUI [1,2]
C0009797
UMLS CUI [2,1]
C0600109
UMLS CUI [2,2]
C1519316
UMLS CUI [2,3]
C0009797
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Does the participant have current therapy with angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)?
Descrizione

ACE or ARB therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2827774
UMLS CUI [1,2]
C0003015
UMLS CUI [2,1]
C2827774
UMLS CUI [2,2]
C0521942
Does the participant have a known intolerance to ACE inhibitor or ARB?
Descrizione

ACE inhibitor or ARB intolerance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0003015
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0521942
Does the participant have a history of angioedema?
Descrizione

History of angioedema

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0002994
Does the participant have a conventional indication for ACE inhibitor or ARB (e.g., history of myocardial infarction, known cardiomyopathy)?
Descrizione

Conventional indication for ACE inhibitor or ARB

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0439858
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0003015
UMLS CUI [2,1]
C0439858
UMLS CUI [2,2]
C3146298
UMLS CUI [2,3]
C0521942
Does the participant have renal insufficiency (GFR <30 mL/min by Cockcroft-Gault calculation)?
Descrizione

Renal insufficiency

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C4544895
Does the participant have current regular use of NSAIDs defined as daily use 5 or more days of the week for more than one month?
Descrizione

Current regular NSAID use

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C0205272
UMLS CUI [1,3]
C0003211
Does the participant have a potassium supplementation or serum potassium level of 5.0 milliequivalents (mEq)/dL or higher at V1?
Descrizione

Potassium supplementation or serum potassium level

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0561938
UMLS CUI [2,1]
C0302353
UMLS CUI [2,2]
C0205250
Does the participant have a current use of a potassium sparing diuretic?
Descrizione

Current potassium sparing diuretic

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C0304490
Does the participant have a COPD exacerbation requiring treatment within 6 weeks at V1?
Descrizione

COPD exacerbation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0740304
UMLS CUI [1,2]
C0027552
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0332185
Does the participant have a chronic systemic corticosteroid use of more than 10mg/day of prednisone?
Descrizione

Chronic systemic corticosteroid use

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0205191
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0239126
Does the participant have a resting SpO2 <89% on 2 L nasal cannula continuous flow; unless at altitude > 4,000 feet, then resting oxygen saturation (SpO2) <89% on 4 L N C continuous flow?
Descrizione

Resting SpO2

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4699029
UMLS CUI [1,2]
C0428179
UMLS CUI [1,3]
C0205251
UMLS CUI [1,4]
C2016156
UMLS CUI [1,5]
C4531406
UMLS CUI [2,1]
C0238617
UMLS CUI [2,2]
C4699029
UMLS CUI [2,3]
C0428179
UMLS CUI [2,4]
C0205251
UMLS CUI [2,5]
C2016156
UMLS CUI [2,6]
C0205250
UMLS CUI [2,7]
C4531406
Does the participant have untreated arterial hypertension (systolic blood pressure greater than140 mm Hg, diastolic blood pressure greater than 90 mm Hg)?
Descrizione

Untreated arterial hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0745134
UMLS CUI [2]
C0277884
UMLS CUI [3]
C0277889
Does the participant have blood pressure less than 90 mm Hg systolic or 60 mm Hg diastolic while standing or sitting?
Descrizione

Low blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0231472
UMLS CUI [1,2]
C0277885
UMLS CUI [2,1]
C0231472
UMLS CUI [2,2]
C0277890
UMLS CUI [3,1]
C0277814
UMLS CUI [3,2]
C0277885
UMLS CUI [4,1]
C0277814
UMLS CUI [4,2]
C0277890
Does the participant have known unilateral or bilateral renal artery stenosis higher than 70%?
Descrizione

Unilateral/Bilateral renal artery stenosis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0205309
UMLS CUI [1,2]
C0856759
UMLS CUI [1,3]
C0205082
UMLS CUI [2,1]
C0205309
UMLS CUI [2,2]
C0856760
UMLS CUI [2,3]
C0205082
Does the participant have a previous lung resection surgery?
Descrizione

Previous lung resection surgery

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0205156
UMLS CUI [1,2]
C0396565
Does the participant have evidence of interstitial, occupational or chronic infectious lung disease?
Descrizione

Infectious lung disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332120
UMLS CUI [1,2]
C0596790
UMLS CUI [1,3]
C0876973
UMLS CUI [2,1]
C0332120
UMLS CUI [2,2]
C0521127
UMLS CUI [2,3]
C0876973
UMLS CUI [3,1]
C0332120
UMLS CUI [3,2]
C0205191
UMLS CUI [3,3]
C0876973
Does the participant have changes to chest that preclude adequate HRCT imaging (e.g. Metallic objects in the chest such as shrapnel or pacemaker leads)?
Descrizione

Changes to chest precluding HRCT

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392747
UMLS CUI [1,2]
C0817096
UMLS CUI [1,3]
C4743675
UMLS CUI [1,4]
C0412612
UMLS CUI [2]
C2826620
UMLS CUI [3]
C0522670
UMLS CUI [4]
C1283151
Does the participant have a positive pregnancy test or unwillingness to use two methods of birth control or abstinence for the duration of the study?
Descrizione

For women of child bearing potential

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0240802
UMLS CUI [2,1]
C0558080
UMLS CUI [2,2]
C0004764
UMLS CUI [2,3]
C0489652
UMLS CUI [3,1]
C0558080
UMLS CUI [3,2]
C0036899
UMLS CUI [3,3]
C0489652
Does the participant have a major chronic illnesses which in the judgment of the study physician would interfere with participation in the study e.g. including but not limited to: cardiac, renal, hepatic (LFTs more than 2.5x normal upper limit), neurological, psychiatric, endocrine or neoplastic diseases, uncontrolled diabetes, uncontrolled HIV infection or other immune system disorder, hyperthyroidism, seizure disorders, non-skin cancer, rheumatic diseases?
Descrizione

Major chronic illnesses

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348568
UMLS CUI [2]
C0018799
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0023895
UMLS CUI [5]
C0027765
UMLS CUI [6]
C0004936
UMLS CUI [7]
C0014130
UMLS CUI [8]
C1882062
UMLS CUI [9]
C2733146
UMLS CUI [10]
C2732402
UMLS CUI [11,1]
C0019693
UMLS CUI [11,2]
C0205318
UMLS CUI [12]
C1532237
UMLS CUI [13]
C0020550
UMLS CUI [14]
C0014544
UMLS CUI [15,1]
C0006826
UMLS CUI [15,2]
C4723751
UMLS CUI [15,3]
C1123023
UMLS CUI [16]
C3495832
Does the participant have a failure to keep screening appointments or other indicators of non-adherence?
Descrizione

Non-adherence

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680095
UMLS CUI [1,2]
C0545082
UMLS CUI [1,3]
C1710032
UMLS CUI [2,1]
C0021212
UMLS CUI [2,2]
C0457432
Does the participant have an inability to be contacted by telephone?
Descrizione

No telephone contact

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1299582
UMLS CUI [1,2]
C0332158
UMLS CUI [1,3]
C0039457
Does the participant have the intention to leave area within 12 months?
Descrizione

Intention to leave area soon

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1283828
UMLS CUI [1,2]
C1706081
UMLS CUI [1,3]
C0205146
UMLS CUI [1,4]
C4018905

Similar models

Eligibility Criteria

  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Mild to severe COPD
Item
Does the participant have mild to severe COPD: Ratio of forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) less than or equal to 0.70, FEV1 20-80% of predicted?
boolean
C2945599 (UMLS CUI [1,1])
C0024117 (UMLS CUI [1,2])
C0205082 (UMLS CUI [2,1])
C0024117 (UMLS CUI [2,2])
C0438193 (UMLS CUI [3])
C0860907 (UMLS CUI [4])
Current or former smoker
Item
Is the participant a current or former smoker?
boolean
C3241966 (UMLS CUI [1])
C0337671 (UMLS CUI [2])
HRCT scan
Item
Does the participant have a HRCT scan with 5-35% of voxels with density less than -950 Hounsfield Units (HU)?
boolean
C0412612 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C2700259 (UMLS CUI [1,3])
C0178587 (UMLS CUI [1,4])
C0205251 (UMLS CUI [1,5])
Informed consent
Item
Does the participant have the ability to understand and willingness to sign consent documents?
boolean
C1273101 (UMLS CUI [1,1])
C0009797 (UMLS CUI [1,2])
C0600109 (UMLS CUI [2,1])
C1519316 (UMLS CUI [2,2])
C0009797 (UMLS CUI [2,3])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
ACE or ARB therapy
Item
Does the participant have current therapy with angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)?
boolean
C2827774 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C2827774 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
ACE inhibitor or ARB intolerance
Item
Does the participant have a known intolerance to ACE inhibitor or ARB?
boolean
C1744706 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
History of angioedema
Item
Does the participant have a history of angioedema?
boolean
C0262926 (UMLS CUI [1,1])
C0002994 (UMLS CUI [1,2])
Conventional indication for ACE inhibitor or ARB
Item
Does the participant have a conventional indication for ACE inhibitor or ARB (e.g., history of myocardial infarction, known cardiomyopathy)?
boolean
C0439858 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0003015 (UMLS CUI [1,3])
C0439858 (UMLS CUI [2,1])
C3146298 (UMLS CUI [2,2])
C0521942 (UMLS CUI [2,3])
Renal insufficiency
Item
Does the participant have renal insufficiency (GFR <30 mL/min by Cockcroft-Gault calculation)?
boolean
C1565489 (UMLS CUI [1])
C4544895 (UMLS CUI [2])
Current regular NSAID use
Item
Does the participant have current regular use of NSAIDs defined as daily use 5 or more days of the week for more than one month?
boolean
C0521116 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0003211 (UMLS CUI [1,3])
Potassium supplementation or serum potassium level
Item
Does the participant have a potassium supplementation or serum potassium level of 5.0 milliequivalents (mEq)/dL or higher at V1?
boolean
C0561938 (UMLS CUI [1])
C0302353 (UMLS CUI [2,1])
C0205250 (UMLS CUI [2,2])
Current potassium sparing diuretic
Item
Does the participant have a current use of a potassium sparing diuretic?
boolean
C0521116 (UMLS CUI [1,1])
C0304490 (UMLS CUI [1,2])
COPD exacerbation
Item
Does the participant have a COPD exacerbation requiring treatment within 6 weeks at V1?
boolean
C0740304 (UMLS CUI [1,1])
C0027552 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
Chronic systemic corticosteroid use
Item
Does the participant have a chronic systemic corticosteroid use of more than 10mg/day of prednisone?
boolean
C0205191 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0239126 (UMLS CUI [1,3])
Resting SpO2
Item
Does the participant have a resting SpO2 <89% on 2 L nasal cannula continuous flow; unless at altitude > 4,000 feet, then resting oxygen saturation (SpO2) <89% on 4 L N C continuous flow?
boolean
C4699029 (UMLS CUI [1,1])
C0428179 (UMLS CUI [1,2])
C0205251 (UMLS CUI [1,3])
C2016156 (UMLS CUI [1,4])
C4531406 (UMLS CUI [1,5])
C0238617 (UMLS CUI [2,1])
C4699029 (UMLS CUI [2,2])
C0428179 (UMLS CUI [2,3])
C0205251 (UMLS CUI [2,4])
C2016156 (UMLS CUI [2,5])
C0205250 (UMLS CUI [2,6])
C4531406 (UMLS CUI [2,7])
Untreated arterial hypertension
Item
Does the participant have untreated arterial hypertension (systolic blood pressure greater than140 mm Hg, diastolic blood pressure greater than 90 mm Hg)?
boolean
C0745134 (UMLS CUI [1])
C0277884 (UMLS CUI [2])
C0277889 (UMLS CUI [3])
Low blood pressure
Item
Does the participant have blood pressure less than 90 mm Hg systolic or 60 mm Hg diastolic while standing or sitting?
boolean
C0231472 (UMLS CUI [1,1])
C0277885 (UMLS CUI [1,2])
C0231472 (UMLS CUI [2,1])
C0277890 (UMLS CUI [2,2])
C0277814 (UMLS CUI [3,1])
C0277885 (UMLS CUI [3,2])
C0277814 (UMLS CUI [4,1])
C0277890 (UMLS CUI [4,2])
Unilateral/Bilateral renal artery stenosis
Item
Does the participant have known unilateral or bilateral renal artery stenosis higher than 70%?
boolean
C0205309 (UMLS CUI [1,1])
C0856759 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C0205309 (UMLS CUI [2,1])
C0856760 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
Previous lung resection surgery
Item
Does the participant have a previous lung resection surgery?
boolean
C0205156 (UMLS CUI [1,1])
C0396565 (UMLS CUI [1,2])
Infectious lung disease
Item
Does the participant have evidence of interstitial, occupational or chronic infectious lung disease?
boolean
C0332120 (UMLS CUI [1,1])
C0596790 (UMLS CUI [1,2])
C0876973 (UMLS CUI [1,3])
C0332120 (UMLS CUI [2,1])
C0521127 (UMLS CUI [2,2])
C0876973 (UMLS CUI [2,3])
C0332120 (UMLS CUI [3,1])
C0205191 (UMLS CUI [3,2])
C0876973 (UMLS CUI [3,3])
Changes to chest precluding HRCT
Item
Does the participant have changes to chest that preclude adequate HRCT imaging (e.g. Metallic objects in the chest such as shrapnel or pacemaker leads)?
boolean
C0392747 (UMLS CUI [1,1])
C0817096 (UMLS CUI [1,2])
C4743675 (UMLS CUI [1,3])
C0412612 (UMLS CUI [1,4])
C2826620 (UMLS CUI [2])
C0522670 (UMLS CUI [3])
C1283151 (UMLS CUI [4])
Pregnancy test, birth control or abstinence
Item
Does the participant have a positive pregnancy test or unwillingness to use two methods of birth control or abstinence for the duration of the study?
boolean
C0240802 (UMLS CUI [1])
C0558080 (UMLS CUI [2,1])
C0004764 (UMLS CUI [2,2])
C0489652 (UMLS CUI [2,3])
C0558080 (UMLS CUI [3,1])
C0036899 (UMLS CUI [3,2])
C0489652 (UMLS CUI [3,3])
Major chronic illnesses
Item
Does the participant have a major chronic illnesses which in the judgment of the study physician would interfere with participation in the study e.g. including but not limited to: cardiac, renal, hepatic (LFTs more than 2.5x normal upper limit), neurological, psychiatric, endocrine or neoplastic diseases, uncontrolled diabetes, uncontrolled HIV infection or other immune system disorder, hyperthyroidism, seizure disorders, non-skin cancer, rheumatic diseases?
boolean
C0008679 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0018799 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0027765 (UMLS CUI [5])
C0004936 (UMLS CUI [6])
C0014130 (UMLS CUI [7])
C1882062 (UMLS CUI [8])
C2733146 (UMLS CUI [9])
C2732402 (UMLS CUI [10])
C0019693 (UMLS CUI [11,1])
C0205318 (UMLS CUI [11,2])
C1532237 (UMLS CUI [12])
C0020550 (UMLS CUI [13])
C0014544 (UMLS CUI [14])
C0006826 (UMLS CUI [15,1])
C4723751 (UMLS CUI [15,2])
C1123023 (UMLS CUI [15,3])
C3495832 (UMLS CUI [16])
Non-adherence
Item
Does the participant have a failure to keep screening appointments or other indicators of non-adherence?
boolean
C0680095 (UMLS CUI [1,1])
C0545082 (UMLS CUI [1,2])
C1710032 (UMLS CUI [1,3])
C0021212 (UMLS CUI [2,1])
C0457432 (UMLS CUI [2,2])
No telephone contact
Item
Does the participant have an inability to be contacted by telephone?
boolean
C1299582 (UMLS CUI [1,1])
C0332158 (UMLS CUI [1,2])
C0039457 (UMLS CUI [1,3])
Intention to leave area soon
Item
Does the participant have the intention to leave area within 12 months?
boolean
C1283828 (UMLS CUI [1,1])
C1706081 (UMLS CUI [1,2])
C0205146 (UMLS CUI [1,3])
C4018905 (UMLS CUI [1,4])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial